There is no squeeze coming here. The MM will and have been letting shorts out easy and under the radar.
Are you freaking kidding me. A current price of $0.03 to a BO of $0.15. Who cares
You are either thick or dunce. Maybe both. Do you stay up late thinking of all these posts. Whoever pays you is losing money, ARNA is losing money, you are losing money. Give it a rest and change your screen name.
That just means that all these pharma companies don't know how to value a company. It takes time to catch on and with three in the space, it will be a slow ride.
Even if ARNA gets this option to a successful trial, it will be at least 2 more years before it gets to market and 2 1/2 years before they realize any sales. OREX will have put both VVUS and ARNA out to pasture by them. ARNA sane your R & D money for something more useful like toilet paper. When you see how fast OREX passes you will s_it the bed!
It's only down about 38% since early January. I think people have been patient enough with your picks. I advise them to sell and move over to ????
Does anyone have an e-mail address for the Zack N Hack firm? I would like to send them a congratulatory note on there best piece of S_it yet. So pro ARNA. Don't even mention VVUS in article as other companies which would have made their hit piece less obvious. Zack n Hack. Greta article. We've actually gone up more since you released it. Job well done. Was this one of your $5 articles or $7.99 ones??
Why build or buy a factory if you goal is to partner? Stupid irrelevant post. How many approved drugs to ARNA have right now??? How are they doing in Europe?? Thought so.
Oh a death spiral. Hummm up two days in a row. Like that spiral. Actually your terminology is incorrect. It's coiling for large BOING!!!!!
is not only a joke but it's about three days old. They just need to keep this generic threat alive. According to the author this is a major setback. Can't quite see it that way but then again I'm not trying to sway people like they are. The sales are gaining traction in the US. Forget about VVUS, they will pull the plug soon if they keep losing share. ARNA is currently on top but also losing ground by about 5% a week. This frivolous attempt is just going to cost them some legal fees. If that's a set back then I am crazy. One milestone payment from Takeda should more than cover it. They are ready to submit a new study and are looking for a partner to handle 33 countries. I would say that this is not a Major setback. Just another misguided, on-sided hit piece that will get refuted many times. Zack thanks for showing us all what type of business model you like to run!
On problem, their PPS stinks and each week they lose more ground to Contrave. By the end of May, you will forget about Belviq. It will be a pure alternate option by then.